Suppr超能文献

偏 M 型受体阳性变构调节剂揭示了磷脂酶 D 在 M 型受体依赖性啮齿动物皮质可塑性中的作用。

Biased M receptor-positive allosteric modulators reveal role of phospholipase D in M-dependent rodent cortical plasticity.

机构信息

Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN 37232, USA.

Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.

出版信息

Sci Signal. 2019 Dec 3;12(610):eaax2057. doi: 10.1126/scisignal.aax2057.

Abstract

Highly selective, positive allosteric modulators (PAMs) of the M subtype of muscarinic acetylcholine receptor have emerged as an exciting new approach to potentially improve cognitive function in patients suffering from Alzheimer's disease and schizophrenia. Discovery programs have produced a structurally diverse range of M receptor PAMs with distinct pharmacological properties, including different extents of agonist activity and differences in signal bias. This includes biased M receptor PAMs that can potentiate coupling of the receptor to activation of phospholipase C (PLC) but not phospholipase D (PLD). However, little is known about the role of PLD in M receptor signaling in native systems, and it is not clear whether biased M PAMs display differences in modulating M-mediated responses in native tissue. Using PLD inhibitors and PLD knockout mice, we showed that PLD was necessary for the induction of M-dependent long-term depression (LTD) in the prefrontal cortex (PFC). Furthermore, biased M PAMs that did not couple to PLD not only failed to potentiate orthosteric agonist-induced LTD but also blocked M-dependent LTD in the PFC. In contrast, biased and nonbiased M PAMs acted similarly in potentiating M-dependent electrophysiological responses that were PLD independent. These findings demonstrate that PLD plays a critical role in the ability of M PAMs to modulate certain central nervous system (CNS) functions and that biased M PAMs function differently in brain regions implicated in cognition.

摘要

高度选择性的、毒蕈碱乙酰胆碱受体 M 亚型的正变构调节剂(PAMs)作为一种有前途的新方法出现,可能改善阿尔茨海默病和精神分裂症患者的认知功能。发现计划产生了具有不同药理特性的结构多样的 M 受体 PAMs,包括不同程度的激动剂活性和信号偏向的差异。这包括偏向 M 受体 PAMs,其可以增强受体与磷脂酶 C(PLC)的激活偶联,但不与磷脂酶 D(PLD)偶联。然而,对于 PLC 在天然系统中的 M 受体信号转导中的作用知之甚少,也不清楚偏向 M PAMs 是否在调节天然组织中 M 介导的反应方面存在差异。使用 PLD 抑制剂和 PLD 敲除小鼠,我们表明 PLD 对于前额叶皮层(PFC)中 M 依赖性长时程抑制( LTD )的诱导是必需的。此外,不与 PLD 偶联的偏向 M PAMs 不仅不能增强对 M 型激动剂诱导的 LTD,而且还阻断了 PFC 中的 M 依赖性 LTD。相比之下,偏向 M PAMs 和非偏向 M PAMs 在增强与 PLC 无关的 M 依赖性电生理反应方面表现相似。这些发现表明,PLD 在 M PAMs 调节某些中枢神经系统(CNS)功能的能力中起着关键作用,并且偏向 M PAMs 在与认知相关的脑区中的作用不同。

相似文献

2
M-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognition.
Neuropsychopharmacology. 2018 Jul;43(8):1763-1771. doi: 10.1038/s41386-018-0033-9. Epub 2018 Mar 14.
3
Role of mGlu Receptors and Inhibitory Neurotransmission in M Dependent Muscarinic LTD in the Prefrontal Cortex: Implications in Schizophrenia.
ACS Chem Neurosci. 2017 Oct 18;8(10):2254-2265. doi: 10.1021/acschemneuro.7b00167. Epub 2017 Aug 9.
4
Probing the binding site of novel selective positive allosteric modulators at the M muscarinic acetylcholine receptor.
Biochem Pharmacol. 2018 Aug;154:243-254. doi: 10.1016/j.bcp.2018.05.009. Epub 2018 May 17.
5
Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model.
Neuropsychopharmacology. 2016 Jan;41(2):598-610. doi: 10.1038/npp.2015.189. Epub 2015 Jun 25.
6
PF-06827443 Displays Robust Allosteric Agonist and Positive Allosteric Modulator Activity in High Receptor Reserve and Native Systems.
ACS Chem Neurosci. 2018 Sep 19;9(9):2218-2224. doi: 10.1021/acschemneuro.8b00106. Epub 2018 Apr 25.
7
Diverse Effects on M Signaling and Adverse Effect Liability within a Series of M Ago-PAMs.
ACS Chem Neurosci. 2017 Apr 19;8(4):866-883. doi: 10.1021/acschemneuro.6b00429. Epub 2017 Jan 10.
9
A Novel M PAM VU0486846 Exerts Efficacy in Cognition Models without Displaying Agonist Activity or Cholinergic Toxicity.
ACS Chem Neurosci. 2018 Sep 19;9(9):2274-2285. doi: 10.1021/acschemneuro.8b00131. Epub 2018 May 8.
10
Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M PAM VU6004256.
ACS Chem Neurosci. 2016 Dec 21;7(12):1706-1716. doi: 10.1021/acschemneuro.6b00230. Epub 2016 Oct 5.

引用本文的文献

1
Targeting the M1 muscarinic acetylcholine receptor in Alzheimer's disease.
Neuronal Signal. 2022 Apr 21;6(1):NS20210004. doi: 10.1042/NS20210004. eCollection 2022 Apr.
2
Targeting muscarinic receptors to treat schizophrenia.
Behav Brain Res. 2021 May 7;405:113201. doi: 10.1016/j.bbr.2021.113201. Epub 2021 Feb 26.
3
Fine Tuning Muscarinic Acetylcholine Receptor Signaling Through Allostery and Bias.
Front Pharmacol. 2021 Jan 29;11:606656. doi: 10.3389/fphar.2020.606656. eCollection 2020.
4
Targeting Muscarinic Acetylcholine Receptors for the Treatment of Psychiatric and Neurological Disorders.
Trends Pharmacol Sci. 2019 Dec;40(12):1006-1020. doi: 10.1016/j.tips.2019.10.007. Epub 2019 Nov 8.

本文引用的文献

1
M Muscarinic Receptors Modulate Fear-Related Inputs to the Prefrontal Cortex: Implications for Novel Treatments of Posttraumatic Stress Disorder.
Biol Psychiatry. 2019 Jun 15;85(12):989-1000. doi: 10.1016/j.biopsych.2019.02.020. Epub 2019 Mar 7.
2
Mechanisms underlying prelimbic prefrontal cortex mGlu/mGlu-dependent plasticity and reversal learning deficits following acute stress.
Neuropharmacology. 2019 Jan;144:19-28. doi: 10.1016/j.neuropharm.2018.10.013. Epub 2018 Oct 13.
4
Mechanisms of signalling and biased agonism in G protein-coupled receptors.
Nat Rev Mol Cell Biol. 2018 Oct;19(10):638-653. doi: 10.1038/s41580-018-0049-3.
5
Psychotic Disorders.
N Engl J Med. 2018 Jul 19;379(3):270-280. doi: 10.1056/NEJMra1801490.
6
Probing the binding site of novel selective positive allosteric modulators at the M muscarinic acetylcholine receptor.
Biochem Pharmacol. 2018 Aug;154:243-254. doi: 10.1016/j.bcp.2018.05.009. Epub 2018 May 17.
7
A Novel M PAM VU0486846 Exerts Efficacy in Cognition Models without Displaying Agonist Activity or Cholinergic Toxicity.
ACS Chem Neurosci. 2018 Sep 19;9(9):2274-2285. doi: 10.1021/acschemneuro.8b00131. Epub 2018 May 8.
8
PF-06827443 Displays Robust Allosteric Agonist and Positive Allosteric Modulator Activity in High Receptor Reserve and Native Systems.
ACS Chem Neurosci. 2018 Sep 19;9(9):2218-2224. doi: 10.1021/acschemneuro.8b00106. Epub 2018 Apr 25.
9
M-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognition.
Neuropsychopharmacology. 2018 Jul;43(8):1763-1771. doi: 10.1038/s41386-018-0033-9. Epub 2018 Mar 14.
10
Differential Pharmacology and Binding of mGlu Receptor Allosteric Modulators.
Mol Pharmacol. 2018 May;93(5):526-540. doi: 10.1124/mol.117.110114. Epub 2018 Mar 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验